| Literature DB >> 27175335 |
Jinju Nie1, Dezhi Yang1, Kun Hu1, Yang Lu1.
Abstract
Bifendate, a synthetic anti-hepatitis drug, exhibits polycrystalline mode phenomena with 2 polymorphs reported (forms A and B). Single crystals of the known crystalline form B and 3 new crystallosolvates involving bifendate solvated with tetrahydrofuran (C), dioxane (D), and pyridine (E) in a stoichiometric ratio of 1:1 were obtained and characterized by X-ray crystallography, thermal analysis, and Fourier transform infrared (FT-IR) spectroscopy. The differences in molecular conformation, intermolecular interaction and crystal packing arrangement for the four polymorphs were determined and the basis for the polymorphisms was investigated. The rotation of single bonds resulted in different orientations for the biphenyl, methyl ester and methoxyl groups. All guest solvent molecules interacted with the host molecule via an interesting intercalative mode along the [1 0 0] direction in the channel formed by the host molecules through weak aromatic stacking interactions or non-classical hydrogen bonds, of which the volume and planarity played an important role in the intercalation of the host with the guest. The incorporation of solvent-augmented rotation of the C-C bond of the biphenyl group had a striking effect on the host molecular conformation and contributed to the formation of bifendate polymorphs. Moreover, the simulated powder X-ray diffraction (PXRD) patterns for each form were calculated on the basis of the single-crystal data and proved to be unique. The single-crystal structures of the four crystalline forms are reported in this paper.Entities:
Keywords: ADPs, anisotropic displacement parameters; ALT, alanine transaminase; Bifendate; CCDC, Cambridge crystallographic data center; DDB, dimethyl dimethoxy biphenyl dicarboxylate; DSC, differential scanning calorimetry; FT-IR; FT-IR, Fourier transform infrared spectroscopy; MW, molecular weight; PXRD, powder X-ray diffraction; Polymorphism; SCXRD, single-crystal X-ray diffraction; Single-crystal structure; Solvatomorphism; TGA, thermal gravimetric analyzer.; Thermal analysis
Year: 2016 PMID: 27175335 PMCID: PMC4856952 DOI: 10.1016/j.apsb.2016.03.006
Source DB: PubMed Journal: Acta Pharm Sin B ISSN: 2211-3835 Impact factor: 11.413
Figure 1Chemical structure and structural overlay for forms B–E of bifendate. Eight molecules of form B are in different colors, solvate C is in red, solvate D is in blue, solvate E is in green. (A) Chemical structure of bifendate; (B) overlay of eight molecules of form B; (C) overlay of solvates C–E.
Crystallographic data and experimental details for four crystalline forms of bifendate.
| Parameter | Form B | Form C | Form D | Form E |
|---|---|---|---|---|
| Empirical formula | C20H18O10 | C20H18O10·C4H8O | C20H18O10·C4H8O2 | C20H18O10·C5H5N |
| Molecular weight (Da) | 418.36 | 490.45 | 506.45 | 497.44 |
| Crystal system | Triclinic | Orthorhombic | Orthorhombic | Orthorhombic |
| Space group | P | P na21 | P 212121 | P na21 |
| Color/shape | Colorless/Prism | Colorless/Prism | Colorless/Prism | Colorless/Prism |
| Crystal size (mm3) | 0.45×0.60×0.79 | 0.19×0.27×0.61 | 0.39×0.78×0.83 | 0.59×0.76×0.99 |
| Temperature (K) | 293(2) | 293(2) | 293(2) | 293(2) |
| 16.305(3) | 8.516(2) | 8.473(3) | 8.555(2) | |
| 16.312(3) | 21.957(4) | 12.529(3) | 22.243(4) | |
| 29.042(6) | 12.429(2) | 22.728(5) | 12.207(2) | |
| 97.68(3) | 90.00 | 90.00 | 90.00 | |
| 97.64(3) | 90.00 | 90.00 | 90.00 | |
| 90.03(3) | 90.00 | 90.00 | 90.00 | |
| Volume (Å3) | 7,586(3) | 2,324.0(8) | 2,412.8(12) | 2,322.8(8) |
| 16 | 4 | 4 | 4 | |
| 1.465 | 1.402 | 1.394 | 1.422 | |
| 3,488 | 1,032 | 1,064 | 1,040 | |
| Absorption coefficient (mm−1) | 1.023 | 0.950 | 0.965 | 0.943 |
| Theta range for data collection (°) | 1.55–72.65 | 4.03–72.21 | 3.89–71.72 | 3.97–71.97 |
| Reflections collected | 107,349 | 12,118 | 14,611 | 14,776 |
| Independent reflections | 28,817 | 3,871 | 4,521 | 3,291 |
| 0.0933 | 0.0487 | 0.0623 | 0.0636 | |
| 0.0654 | 0.0530 | 0.0454 | 0.0522 | |
| 0.1571 | 0.1445 | 0.1149 | 0.1279 | |
| 0.0904 | 0.0579 | 0.0482 | 0.0535 | |
| 0.1765 | 0.1533 | 0.1190 | 0.1299 | |
| Goodness-of-fit on | 0.998 | 1.045 | 1.059 | 1.064 |
| Completeness | 0.956 | 0.990 | 0.986 | 0.978 |
| CCDC deposition number | 1,432,083 | 1,432,084 | 1,432,085 | 1,432,086 |
Dihedral angles between the ring planes linked by C–C bond of the biphenyl group.
| Form | ∠R1–R2 (°) |
|---|---|
| B (A) | 71.3 |
| C | 125.3 |
| D | 125.7 |
| E | 126.7 |
R1 denotes the C1/C2/C3/C4/C5/O4/C16/O5/C6 ring; R2 denotes the C7/C12/C11/C10/C9/O7/C17/O6/C8 ring.
Torsion angle values describing conformational states of bifendate molecules in four forms studied.
| Form | ∠C6–C1–C7–C8 | ∠C15–O3–C4–C3 | ∠C1–C2–C13–O1 | ∠C7–C12–C19–O9 | ∠C18–O8–C10–C11 |
|---|---|---|---|---|---|
| B (A/C) | 69.3(3)/−69.3(3) | −6.4(3)/5.5(3) | 21.8(4)/−25.1(4) | 24.4(4)/−23.5(3) | −3.4(3)/7.9(3) |
| C | 120.7(3) | 9.5(6) | −25.6(5) | −28.7(5) | −5.8(5) |
| D | −121.3(2) | −11.8(4) | 27.8(3) | 27.2(3) | −1.6(4) |
| E | 122.1(3) | −7.2(5) | −30.2(4) | −25.9(4) | 9.6(5) |
Figure 2Stereochemical structure of form B: (A) a view of the one-dimensional catenoid structure of form B along [0 0 1] direction; (B) a view of the two-dimensional layer structure of form B along (0 0 1) plane. Molecules are shown as wireframe models and hydrogen atoms are omitted for clarity.
Figure 3Upper row: layered structures of solvates C–E with solvent molecules located in the channels between the layers for (A) solvate C: tetrahydrofuran, view down c axis; (B) solvate D: dioxane, view down b axis; (C) solvate E: pyridine, view down c axis. Solvent molecules are represented by spheres corresponding with the van der Waals radii of the respective atoms. Hydrogen atoms are omitted for clarity. Lower row: space-filling representation of bifendate showing the continuous channels along [1 0 0] viewed down crystallographic a axis for (D) solvate C: tetrahydrofuran; (E) solvate D: dioxane and (F) solvate E: pyridine. Bifendate molecules are represented by spheres corresponding with the van der Waals radii of the respective atoms. Solvents are omitted for clarity.
Figure 4Simulated PXRD pattern for form B and comparison of the simulated PXRD patterns for solvates C–E and those after deducting solvents of bifendate. (A) form B; (B) solvate C: tetrahydrofuran; 0.5 solvated; unsolvated; (C) solvate D: dioxane; 0.5 solvated; unsolvated; (D) solvate E: pyridine; 0.5 solvated and unsolvated.
Figure 5Thermal analysis profiles of forms B–E. (A) DSC profiles of forms B–E; (B) TGA profiles of forms B–E. Profiles of forms B–E are indicated with black, red, blue, and green, respectively. Top to bottom: form B; solvate C: tetrahydrofuran; solvate D: dioxane; and solvate E: pyridine.
DSC data for forms B–E of bifendate.
| Form | ||
|---|---|---|
| B | – | 162.82 |
| C | 77.21 | 182.63 |
| D | 128.37 | 181.65 |
| E | 81.42 | 182.11 |
Figure 6Infrared spectra for forms B to E of bifendate with scanning region of 4000–650 cm−1. Spectra of forms B to E are indicated with solid lines in black, red, blue, and green, respectively. Top to bottom: form B; solvate C: tetrahydrofuran; solvate D: dioxane; and solvate E: pyridine.